Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Shanghai RAAS Blood Products Co., Ltd.

Capitalization 4.1TCr 594.81Cr 518.08Cr 469.09Cr 447.52Cr 814.07Cr 55TCr 844.04Cr 5.57TCr 2.22TCr 26TCr 2.23TCr 2.19TCr 95TCr P/E ratio 2025 *
20.7x
P/E ratio 2026 * 17.7x
Enterprise value 4.1TCr 594.81Cr 518.08Cr 469.09Cr 447.52Cr 814.07Cr 55TCr 844.04Cr 5.57TCr 2.22TCr 26TCr 2.23TCr 2.19TCr 95TCr EV / Sales 2025 *
5.23x
EV / Sales 2026 * 4.68x
Free-Float
69.51%
Yield 2025 *
1.29%
Yield 2026 * 1.45%
1 week-0.48%
Current month-1.27%
1 month-0.48%
3 months-2.82%
6 months-10.00%
Current year-2.05%
1 week 6.19
Extreme 6.19
6.28
1 month 6.14
Extreme 6.14
6.4
Current year 6.14
Extreme 6.14
6.57
1 year 6.14
Extreme 6.14
7.3
3 years 5.93
Extreme 5.93
8.68
5 years 4.98
Extreme 4.98
8.68
10 years 4.98
Extreme 4.98
23.88
Manager TitleAgeSince
Chief Executive Officer 62 -
Director of Finance/CFO 39 26/10/2021
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 62 21/05/2020
Chairman 56 30/07/2024
Chairman 62 -
Change 5d. change 1-year change 3-years change Capi.($)
0.00%-0.48%-12.29%-0.16% 594.81Cr
+0.07%-1.99%+11.53%+1.20% 7.77TCr
+1.69%-1.52%+40.20%+230.66% 5.57TCr
+1.21%+58.70%+58.70%+58.70% 4.86TCr
+0.35%-0.75%-43.55%-51.21% 4.77TCr
+0.10%-2.52%+27.95%-30.21% 2.69TCr
+0.91%-0.80%+57.13%-63.64% 2.11TCr
-0.12%+2.75%+105.13%+97.18% 1.86TCr
+0.68%-2.21%+51.43%+27.55% 1.85TCr
+1.70%-1.18%+33.80%+58.02% 1.39TCr
Average +0.66%-1.83%+33.00%+32.81% 3.35TCr
Weighted average by Cap. +0.68%-2.18%+27.42%+42.82%

Financials

2025 *2026 *
Net sales 784.23Cr 113.73Cr 99Cr 90Cr 86Cr 155.66Cr 10TCr 161.39Cr 1.07TCr 423.52Cr 5.02TCr 426.81Cr 417.79Cr 18TCr 876.33Cr 127.09Cr 110.69Cr 100.23Cr 96Cr 173.94Cr 12TCr 180.34Cr 1.19TCr 473.26Cr 5.61TCr 476.93Cr 466.85Cr 20TCr
Net income 201.83Cr 29Cr 25Cr 23Cr 22Cr 40Cr 2.7TCr 42Cr 274.3Cr 109Cr 1.29TCr 109.85Cr 107.52Cr 4.66TCr 230.87Cr 33Cr 29Cr 26Cr 25Cr 46Cr 3.09TCr 48Cr 313.76Cr 124.68Cr 1.48TCr 125.65Cr 122.99Cr 5.33TCr
Net Debt - -
Logo Shanghai RAAS Blood Products Co., Ltd.
Shanghai RAAS Blood Products Co., Ltd. specializes in the research, development and manufacturing of plasma-derived therapeutics. The group's products include human albumin, immunoglobulin and coagulation factors (thrombin, fibrinogen, prothrombin and fibrin). China accounts for 96.6% of net sales.
Employees
3,350
Date Price Change Volume
17/26/17 6.210 ¥ 0.00% 3,09,35,800
16/26/16 6.210 ¥ -0.32% 2,45,00,840
13/26/13 6.230 ¥ -0.48% 2,62,77,940
12/26/12 6.260 ¥ -0.16% 2,43,33,970
11/26/11 6.270 ¥ +0.48% 2,45,58,250
Trader
-
Investor
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
6.210
Average target price
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 002252 Stock
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW